Skip to main content
IC
Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
25.33
-0.73 (-2.80%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Novel Immunotherapies
10.59M
Log In
Log In
Log In
Novel Immunotherapies Growth
30.99%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
United States
10.59M
Log In
Log In
Log In
United States Growth
30.99%
Log In
Log In
Log In